CAR-T cell therapy
A type of immunotherapy that reprograms a patient's own T cells to attack cancer.
What it is
CAR-T cell therapy is a type of treatment that uses a patient's own immune system to fight cancer. It involves taking a sample of the patient's T cells, which are a type of immune cell, and reprogramming them in a lab to recognize and attack cancer cells. These reprogrammed T cells are then returned to the patient's body, where they can help fight the cancer.
How it works
To get CAR-T cells, a patient's T cells are collected from their blood and sent to a lab where they are modified to include a special protein called a chimeric antigen receptor (CAR). This CAR allows the T cells to recognize and bind to specific proteins on the surface of cancer cells. Once the CAR-T cells are made, they are infused back into the patient's body, where they can multiply and attack cancer cells.
Why it matters
CAR-T cell therapy may be an important option for some patients with certain types of cancer, particularly those who have not responded to other treatments. In some cases, it can lead to significant improvements in symptoms and quality of life, and may even help some patients go into remission. Researchers are continuing to study CAR-T cell therapy to learn more about its potential benefits and limitations.
This information is provided for general education only and is not medical advice. Always consult a qualified healthcare professional for guidance on your health.